(Date:12/4/2009)...ational Institute of Standards and Technology (NIS...d a new way to introduce magnetic impurities in a ...ng tunneling microscope (STM). Detailed in a recen...o selectively implant atoms in a crystal one at a ...operties on the atomic scale. , A better underst...
(Date:12/4/2009)...Iowa, Dec. 4 Vivakor, In... its shareholders of record on December 1, 2009 wi...of HealthAmerica, Inc. that was previously approve...is a private Nevada corporation of which Vivakor o...hares on the record date. The distribution date is...
(Date:12/4/2009)...ntre for Advanced Micro Nano Technology Products (..., EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP ho...w technologies like nanotechnology, biomaterials a...reation of innovative healthcare products that hel... outcomes of patient care, while opening new marke...
(Date:12/4/2009)...ec. 4 Stemline Therapeutics, Inc. ...s of its IL-3R targeting agents, SL-401 and SL-501...ronic myeloid leukemia (CML) have been selected fo...Meeting of the American Society of Hematology (ASH...09. The poster will be presented by Stemline,s col...
Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Alberta companies delivering new products to the health & medical marketplace 2Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2...lth,Inc. (Nasdaq: GHDX ) today announced that Kim...erations Officer, will present at the BIO CEO &,In... at 10:15 a.m. Eastern,Time., To access the live ...ion, visit the Investor Relations section of Genom...lth.com . Please connect to the website,at least 1...
...,(Nasdaq: ITMN ) today announced results from ope...mber 31, 2007. The company also provided 2008,fina...ent programs., Results for the Fourth Quarter 200...uarter of 2007 of $25.8,million, or $0.66 per shar...0.64 per share, in the fourth quarter of 2006., I...
... Guide New Service Offering, PHILADELPHIA, Feb. 7...h of a new Alzheimer,s risk assessment service,wit...a service agreement,with one of the leading labora...n at Smart Genetics is to provide people with accu...em understand and interpret,their risk and assist ...
Other Biology Technology:InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 2InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 3InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 4InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 5InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 6InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 7InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 8InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 9InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 10InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 11Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 2Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 3Mouse Anti-Human AGTRAP Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human NCLN Polyclonal Antibody, Unconjugated from Abnova Corporation
5' RACE Anchor Primer from Invitrogen
Mouse Anti-Human UGT2B10 Monoclonal Antibody, Unconjugated, Clone 2D9 from Novus Biologicals
Biology Products: